Literature DB >> 16270406

Effect of Helicobacter pylori infection on Bax protein expression in patients with gastric precancerous lesions.

Hai-Feng Liu1, Wei-Wen Liu, Guo-An Wang, Xiao-Chun Teng.   

Abstract

AIM: To investigate the effect of Helicobacter pylori (H pylori) infection on Bax protein expression, and explore the role of H pylori in gastric carcinogenesis.
METHODS: H pylori was assessed by rapid urease test and Warthin-Starry method, and expression of Bax protein was examined immunohistochemically in 72 patients with pre-malignant lesions.
RESULTS: Bax protein was differently expressed in intestinal metaplasia and gastric dysplasia, and showed 63.99% positivity. The positivity of Bax protein expression in H pylori-positive gastric precancerous lesions (72.3%) was significantly higher than that in H pylori-negative gastric precancerous lesions (48.0%, chi2 = 4.191, P<0.05). H pylori infection was well correlated with the expression of Bax protein in gastric precancerous lesions (r = 0.978, P<0.01). After eradication of H pylori, the positivity of Bax protein expression significantly decreased in H pylori-positive gastric precancerous lesions (chi2 = 5.506, P<0.05). In the persisting H pylori-infected patients, the positivity of Bax protein expression was not changed.
CONCLUSION: H pylori infection may be involved in the upregulation of Bax gene, which might be one of the mechanisms of H pylori infection-induced gastric epithelial cell apoptosis. H pylori might act as a tumor promoter in the genesis of gastric carcinoma and eradication of H pylori could inhibit gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16270406      PMCID: PMC4479697          DOI: 10.3748/wjg.v11.i37.5899

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  10 in total

1.  Helicobacter pylori infection.

Authors:  Yvan Vandenplas
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  A pilot study to evaluate stomach cancer risk reduction by Helicobacter pylori eradication.

Authors:  Nobuyuki Hamajima; Keitaro Matuo; Yoshihiro Watanabe; Takashi Suzuki; Tsuneya Nakamura; Akira Matsuura; Kenji Yamao; Kazuhiko Ohashi; Suketami Tominaga
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

Review 3.  Helicobacter pylori and gastrointestinal tract adenocarcinomas.

Authors:  Richard M Peek; Martin J Blaser
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

Review 4.  Gastric cancer: past, present and future.

Authors:  A O Chan; B C Wong; S K Lam
Journal:  Can J Gastroenterol       Date:  2001-07       Impact factor: 3.522

5.  Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori.

Authors:  S Maeda; H Yoshida; Y Mitsuno; Y Hirata; K Ogura; Y Shiratori; M Omata
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

Review 6.  H. pylori and gastric cancer: the Asian enigma.

Authors:  Hiroto Miwa; Mae F Go; Nobuhiro Sato
Journal:  Am J Gastroenterol       Date:  2002-05       Impact factor: 10.864

Review 7.  Molecular biology of gastric cancer.

Authors:  Wa'el El-Rifai; Steven M Powell
Journal:  Semin Radiat Oncol       Date:  2002-04       Impact factor: 5.934

8.  Helicobacter pylori infection and oncogene expressions in gastric carcinoma and its precursor lesions.

Authors:  Jie Wang; David S Chi; George B Kalin; Christina Sosinski; Lou Ellen Miller; Izabela Burja; Eapen Thomas
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

9.  Relationship between nuclear factor-kappaB activation and virulence factors of Helicobacter pylori in Japanese clinical isolates.

Authors:  Shin Maeda; Jazag Amarsanaa; Yuzo Mitsuno; Yoshihiro Hirata; Masao Akanuma; Tsuneo Ikenoue; Keiji Ogura; Haruhiko Yoshida; Yasushi Shiratori; Masao Omata; Jazag Anarsanaa
Journal:  J Gastroenterol Hepatol       Date:  2002-05       Impact factor: 4.029

Review 10.  [Helicobacter pylori infection and gastric diseases--pathogenesis and effects of eradication].

Authors:  Norio Matsukura
Journal:  Gan To Kagaku Ryoho       Date:  2002-08
  10 in total
  7 in total

1.  Differential expression of Bcl-2 and Bax during gastric ischemia-reperfusion of rats.

Authors:  Wei-Li Qiao; Guang-Ming Wang; Yue Shi; Jin-Xia Wu; You-Jian Qi; Jian-Fu Zhang; Hong Sun; Chang-Dong Yan
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

2.  Identification of H. pylori strain specific DNA sequences between two clinical isolates from NUD and gastric ulcer by SSH.

Authors:  Feng-Chan Han; Min Gong; Han-Chong Ng; Bow Ho
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

3.  Apoptotic cell death and its relationship to gastric carcinogenesis.

Authors:  Ferda Bir; Nese Calli-Demirkan; A Cevik Tufan; Metin Akbulut; N Lale Satiroglu-Tufan
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

4.  Lack of CD117 and rare bcl-2 expression in stomach cancer by immunohistochemistry. An immunohistochemical study with review of the literature.

Authors:  Masoud Mireskandari; Ali Fakhr Shafaii; Gian Kayser; Klaus Kayser
Journal:  Diagn Pathol       Date:  2006-05-16       Impact factor: 2.644

5.  Effect of Di(2-ethylhexyl)phthalate on Helicobacter pylori-Induced Apoptosis in AGS Cells.

Authors:  Chuang-Hao Lin; Chien-Yi Wu; Hwang-Shang Kou; Chiao-Yun Chen; Meng-Chuan Huang; Huang-Ming Hu; Meng-Chieh Wu; Chien-Yu Lu; Deng-Chyang Wu; Ming-Tsang Wu; Fu-Chen Kuo
Journal:  Gastroenterol Res Pract       Date:  2013-12-16       Impact factor: 2.260

6.  Lactobacillus plantarum induces apoptosis in gastric cancer cells via modulation of signaling pathways in Helicobacter pylori.

Authors:  Hadi Maleki-Kakelar; Jaber Dehghani; Abolfazl Barzegari; Jaleh Barar; Masoud Shirmohamadi; Javid Sadeghi; Yadollah Omidi
Journal:  Bioimpacts       Date:  2019-06-28

7.  Gastroprotective Effects of Periplaneta americana L. Extract Against Ethanol-Induced Gastric Ulcer in Mice by Suppressing Apoptosis-Related Pathways.

Authors:  Shu Fu; Jiamei Chen; Chen Zhang; Jinfeng Shi; Xin Nie; Yichen Hu; Chaomei Fu; Xiaofang Li; Jinming Zhang
Journal:  Front Pharmacol       Date:  2021-12-15       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.